Preschoolers to Get ADHD Drug Vyvanse in Shire Study

June 12, 2014 4:47 PM

19 0

Shire Plc will study its best-selling treatment for attention deficit hyperactivity disorder in preschool-age children as it seeks to expand the drug’s use.

Shire plans to begin the first of three studies on Vyvanse in 4- to 5-year-olds in the first half of 2015, the Dublin-based company said in a statement today. Given the Food and Drug Administration’s interest in reviewing safety and usage in young children, Shire submitted a proposed pediatric study...

Read more

To category page